Drug Shortage Report for DIASTAT
| Report ID | 201529 |
| Drug Identification Number | 02238162 |
| Brand name | DIASTAT |
| Common or Proper name | DIASTAT |
| Company Name | BAUSCH HEALTH, CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | DIAZEPAM |
| Strength(s) | 5MG |
| Dosage form(s) | GEL |
| Route of administration | RECTAL RECTAL |
| Packaging size | 2pk |
| ATC code | N05BA |
| ATC description | ANXIOLYTICS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2023-07-28 |
| Estimated end date | 2024-01-19 |
| Actual end date | 2024-01-17 |
| Shortage status | Resolved |
| Updated date | 2024-01-18 |
| Company comments | delay in production |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v21 | 2024-01-18 | English | Compare |
| v20 | 2024-01-17 | French | Compare |
| v19 | 2024-01-17 | English | Compare |
| v18 | 2024-01-10 | French | Compare |
| v17 | 2024-01-10 | English | Compare |
| v16 | 2023-12-20 | French | Compare |
| v15 | 2023-12-20 | English | Compare |
| v14 | 2023-12-15 | French | Compare |
| v13 | 2023-12-15 | English | Compare |
| v12 | 2023-11-01 | French | Compare |
| v11 | 2023-11-01 | English | Compare |
| v10 | 2023-10-26 | French | Compare |
| v9 | 2023-10-26 | English | Compare |
| v8 | 2023-09-15 | French | Compare |
| v7 | 2023-09-15 | English | Compare |
| v6 | 2023-08-23 | French | Compare |
| v5 | 2023-08-23 | English | Compare |
| v4 | 2023-08-09 | French | Compare |
| v3 | 2023-08-09 | English | Compare |
| v2 | 2023-08-09 | French | Compare |